Glucotrack, Inc. (GCTK)
About Glucotrack, Inc.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2019
- $208.0K
- Net income
- -$19.4M
- Total assets
- $7.8M
- Market cap
- $1.9M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.9M
- Shares outstanding
- 2.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 10, 2000
Glucotrack, Inc. (GCTK) Stock Price
- Reported a net loss of $19.4M in FY2019.
- Trading 100% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Glucotrack, Inc..
Write a review
News about Glucotrack, Inc.
News & sentiment via Polygon.io
Glucotrack, Inc.: frequently asked questions
Is Glucotrack, Inc. an American company?
Glucotrack, Inc. is a US-based company headquartered in Rutherford, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Glucotrack, Inc. headquartered?
Glucotrack, Inc. is headquartered in Rutherford, New Jersey, United States.
Is Glucotrack, Inc. publicly traded?
Yes — Glucotrack, Inc. is a publicly traded company. Its stock trades under the ticker symbol GCTK on the NASDAQ.
What does Glucotrack, Inc. do?
Glucotrack, Inc. is an American Medical Devices company in the Health & Beauty sector.
